Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone [Phase 4]
A Phase 4 clinical trial update comparing Shared Solutions Plus MS Center Support with Shared Solutions alone in Multiple Sclerosis patients…
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. [Phase 4]
Phase 4 trial evaluating whether taking the antihistamine cetirizine (Zyrtec) before Copaxone injections reduces injection-site reactions in…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis Patients [Phase 2]
This Phase 2 clinical trial evaluating locomotor therapy with a robot-driven gait orthosis in people with multiple sclerosis has completed. …
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
A clinical trial update reports on how titration, analgesics, and BET A nurse support influence acceptance rates for Betaseron treatment in …
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. [Phase 4]
This Phase 4 trial evaluated whether using alcohol wipes before daily Copaxone injections reduces injection-site skin reactions in people wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-04-01FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
FDA approved a supplemental application for TYSABRI (Natalizumab) filed by Biogen Inc. The action represents an approved regulatory update t…
-
CLINICAL_TRIALS trial_result · 2011-03-30Clinical Trial Update: Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment [Phase 4]
Phase 4 clinical trial evaluating biomarkers and response to natalizumab in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of fingolimod (FTY720) in relapsing multiple sclerosis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients [Phase 1]
This Phase 1 study reports the completion of a 12-week safety evaluation of an oral CS-0777 in patients with multiple sclerosis. It summariz…
-
EMA withdrawal · 2011-02-23EMA Application withdrawn: Movectro (cladribine) — Merck Serono Europe Limited
EMA withdrew the application for Movectro (cladribine) by Merck Serono Europe Limited for multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating the efficacy of 3,4-DAP for fatigue in multiple sclerosis completed.
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: Simvastatin Treatment of Patients With Acute Optic Neuritis [Phase 3]
A Phase 3 clinical trial evaluating simvastatin for acute optic neuritis; the study status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: The Multicenter, Open-label, Single-use Autoinjector Convenience Study [Phase 3]
Phase 3 multicenter open-label study assessing autoinjector convenience for an MS therapy; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study [Phase 3]
This Phase 3 multicenter, open-label study evaluated the ease of use of the RebiSmart autoinjector in multiple sclerosis patients; results w…
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
This clinical trial update describes a study examining whether corpus callosum atrophy can predict subsequent cognitive impairment in patien…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study [Phase 3]
Phase 3 BENEFIT trial and its follow-up in newly diagnosed multiple sclerosis completed; results were posted on 2010-11-30 evaluating interf…
-
FDA approval · 2010-11-19FDA Approved: GABLOFEN — Original Application (Piramal Critical Care Inc)
The FDA approved GABLOFEN (baclofen injection) under an original application from Piramal Critical Care Inc, adding a new injectable baclofe…
-
CLINICAL_TRIALS withdrawal · 2010-09-30Clinical Trial Update: Visual Impairment, Oscillopsia and Multiple Sclerosis
A clinical trial investigating visual impairment and oscillopsia in Multiple Sclerosis was terminated.
-
FDA approval · 2010-09-23FDA Approved: KESIMPTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kesimpta (ofatumumab) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2010-09-21FDA Approved: GILENYA — Original Application (Novartis Pharmaceuticals Corporation)
FDA approves GILENYA (fingolimod hydrochloride) through an original application from Novartis Pharmaceuticals Corporation. The approval is f…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of MLN1202 in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis. [Phase 3]
Completed Phase 3 trial evaluating the suitability of the RebiSmart auto-injector for self-injection in relapsing multiple sclerosis patient…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS) [NA]
A completed clinical trial examined the effects of Vitamin D3 supplementation on T cell compartments in individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2010-07-13Clinical Trial Update: Novel Immune Markers in Patients With Multiple Sclerosis
A clinical trial update describing research on novel immune markers in patients with Multiple Sclerosis, sponsored by the University of Wash…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluating Rebif New Formulation (RNF) for relapsing forms of multiple sclerosis has completed, with results posted.